Literature DB >> 25653827

Poor monitoring of physical health in patients referred to a mood disorders service.

David Lack1, Richard I G Holt2, David S Baldwin3.   

Abstract

BACKGROUND: Severe mental illness is associated with significantly increased morbidity and mortality, most commonly from cardiovascular disease. Much of the risk is explicable by potentially modifiable factors such as diabetes and dyslipidaemia, and regular screening of patients with severe mental illness is recommended. Screening and intervention for physical illness among people with schizophrenia is often suboptimal, but little is known about monitoring physical health in patients with affective (mood and anxiety) disorders.
METHOD: Electronic and paper records were examined for evidence of monitoring of cardiovascular disease risk factors in the 12 months prior to assessment in patients attending a tertiary referral specialist service for affective disorders over a period of 39 months. The number of contacts with healthcare services was calculated for each patient to provide an estimate of the opportunities for monitoring.
RESULTS: Notes for 113 patients were examined. The mean number of contacts with outpatient services in the 12 months before assessment was 6.9 (standard deviation 7.7). Documented evidence of physical-health monitoring was seen in only 29 patients: monitoring was more commonly undertaken in patients with recurrent unipolar depression and in those who had undergone recent inpatient treatment. Contacts that could have allowed monitoring of physical health were common. DISCUSSION: Although most patients had multiple contacts with health services in the 12-month period before their assessment in the service, there was little evidence of use of primary-prevention measures to reduce the risks of diabetes and cardiovascular disease in this vulnerable population.

Entities:  

Keywords:  affective disorder; monitoring; physical health

Year:  2015        PMID: 25653827      PMCID: PMC4315671          DOI: 10.1177/2045125314560734

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN: 2045-1253


  17 in total

1.  Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

Authors:  Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

Review 2.  Cardiovascular morbidity and mortality in bipolar disorder.

Authors:  Miriam Weiner; Lois Warren; Jess G Fiedorowicz
Journal:  Ann Clin Psychiatry       Date:  2011-02       Impact factor: 1.567

3.  Physical healthcare of people with severe mental illness: everybody's business!

Authors:  Kamini Vasudev; Brian V Martindale
Journal:  Ment Health Fam Med       Date:  2010-06

Review 4.  Bipolar disorder and metabolic syndrome: an international perspective.

Authors:  Roger S McIntyre; Marlon Danilewitz; Samantha S Liauw; David E Kemp; Ha T T Nguyen; Linda S Kahn; Aaron Kucyi; Joanna K Soczynska; Hanna O Woldeyohannes; Angela Lachowski; Byungsu Kim; Jay Nathanson; Mohammad Alsuwaidan; Valerie H Taylor
Journal:  J Affect Disord       Date:  2010-06-12       Impact factor: 4.839

Review 5.  A systematic review of the mortality of depression.

Authors:  L R Wulsin; G E Vaillant; V E Wells
Journal:  Psychosom Med       Date:  1999 Jan-Feb       Impact factor: 4.312

6.  A UK audit of screening for the metabolic side effects of antipsychotics in community patients.

Authors:  Thomas R E Barnes; Carol Paton; Mary-Rose Cavanagh; Elizabeth Hancock; David M Taylor
Journal:  Schizophr Bull       Date:  2007-05-04       Impact factor: 9.306

Review 7.  Psychiatric diagnosis as an independent risk factor for metabolic disturbances: results from a comprehensive, naturalistic screening program.

Authors:  Ruud van Winkel; Jim van Os; Ivan Celic; Dominique Van Eyck; Martien Wampers; Andre Scheen; Joseph Peuskens; Marc De Hert
Journal:  J Clin Psychiatry       Date:  2008-08       Impact factor: 4.384

8.  Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.

Authors:  William T Regenold; Ramesh K Thapar; Christopher Marano; Sridevi Gavirneni; Prasad V Kondapavuluru
Journal:  J Affect Disord       Date:  2002-06       Impact factor: 4.839

9.  The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness.

Authors:  R I G Holt; T Abdelrahman; M Hirsch; Z Dhesi; T George; T Blincoe; R C Peveler
Journal:  J Psychopharmacol       Date:  2009-03-20       Impact factor: 4.153

10.  Improvement of care for the physical health of patients with severe mental illness: a qualitative study assessing the view of patients and families.

Authors:  Fenneke M van Hasselt; Marian J T Oud; Anton J M Loonen
Journal:  BMC Health Serv Res       Date:  2013-10-21       Impact factor: 2.655

View more
  4 in total

Review 1.  Cardiovascular disease in patients with severe mental illness.

Authors:  René Ernst Nielsen; Jytte Banner; Svend Eggert Jensen
Journal:  Nat Rev Cardiol       Date:  2020-10-30       Impact factor: 32.419

2.  Increased mortality among people with anxiety disorders: total population study.

Authors:  Sandra M Meier; Manuel Mattheisen; Ole Mors; Preben B Mortensen; Thomas M Laursen; Brenda W Penninx
Journal:  Br J Psychiatry       Date:  2016-07-07       Impact factor: 9.319

3.  The DIY Digital Medical Centre.

Authors:  James Kenneth Timmis; Kenneth Timmis
Journal:  Microb Biotechnol       Date:  2017-08-25       Impact factor: 5.813

4.  Effectiveness and cost-effectiveness of a cardiovascular risk prediction algorithm for people with severe mental illness (PRIMROSE).

Authors:  Ella Zomer; David Osborn; Irwin Nazareth; Ruth Blackburn; Alexandra Burton; Sarah Hardoon; Richard Ian Gregory Holt; Michael King; Louise Marston; Stephen Morris; Rumana Omar; Irene Petersen; Kate Walters; Rachael Maree Hunter
Journal:  BMJ Open       Date:  2017-09-05       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.